Cutting-edge research emerging from Florida Atlantic University’s Charles E. Schmidt College of Medicine sheds new light on the correlation between UPF consumption and systemic inflammation, measured by levels of high-sensitivity C-reactive protein (hs-CRP). This biomarker, produced by the liver in response to inflammation, serves as a highly sensitive prognostic tool for cardiovascular disease risk. While prior studies have hinted at adverse outcomes linked with UPFs, nationally representative evidence quantifying inflammatory responses has been scarce. The new study leverages a robust dataset from the National Health and Nutrition Examination Survey (NHANES), including 9,254 U.S. adults, to rigorously analyze this relationship through advanced statistical methodologies, including logistic regression models.

Participants in the study reported a median UPF caloric intake of 35%, spanning a broad spectrum from negligible levels (0% to 19%) in the lowest consumption bracket to an alarming 60% to 79% in the highest. After adjusting for confounding variables such as age, sex, smoking status, physical activity, and existing health indicators, the findings reveal a pronounced association: individuals in the highest UPF intake group exhibited an 11% increased probability of elevated hs-CRP levels relative to those consuming the least. Remarkably, even those occupying the moderate consumption category (40% to 59%) showed a statistically significant 14% increase, underscoring the inflammation-promoting potential of UPFs across a wide exposure range.

The stratified analyses further elucidate demographic nuances influencing inflammation risk. Middle-aged adults, specifically those aged 50 to 59, demonstrated a 26% higher likelihood of heightened hs-CRP compared to young adults aged 18 to 29. Obesity emerged as an especially potent exacerbating factor, conferring an 80% greater risk relative to individuals maintaining a healthy weight. Notably, current smokers exhibited a 17% increase in inflammatory markers compared to those who never smoked, emphasizing the synergistic effects of lifestyle factors alongside diet. Intriguingly, sedentary behavior did not show a statistically significant elevation in inflammation compared with physically active counterparts, a finding that warrants further mechanistic exploration.

The implications of these discoveries reverberate beyond inflammation biomarkers, potentially informing clinical and public health paradigms. Dr. Allison H. Ferris, senior author and chair of the FAU Department of Medicine, highlights the critical need for healthcare professionals to incorporate awareness of UPF intake into preventative strategies. Given hs-CRP’s established role as a predictor of cardiovascular morbidity, reducing consumption of these synthetic, nutrient-poor foods could represent a modifiable target to curtail systemic inflammation and downstream disease.

The pathophysiological mechanisms by which UPFs elevate hs-CRP levels involve complex interactions between dietary constituents and the body’s immune system. The profusion of additives, preservatives, emulsifiers, and artificial sweeteners disrupts gut microbiota balance, promotes endotoxemia, and triggers chronic low-grade inflammation. These biochemical perturbations may culminate in endothelial dysfunction, insulin resistance, and atherosclerotic plaque development, pathologies intricately linked to increased cardiovascular risk. Furthermore, this pro-inflammatory milieu may extend to oncogenic processes, lending credence to observed rises in colorectal cancer rates, particularly among younger demographics increasingly exposed to UPFs.

The study’s timing aligns with growing epidemiological concerns over metabolic disorders and cardiovascular disease prevalence in the United States. Researchers emphasize that the ubiquity and aggressive marketing of ultra-processed products mirror historical tobacco industry patterns, with multinational corporations exerting substantial influence over dietary habits. Drawing on lessons from decades of tobacco control efforts, the authors advocate for a multipronged approach encompassing policy reform, nutritional education, and industry regulation to mitigate UPF consumption.

Government initiatives might include tightening regulations on harmful additives, enhancing transparency through improved food labeling, and incentivizing whole-food options in federally supported nutrition programs and educational institutions. These strategies address both supply-side and demand-side drivers, recognizing that socioeconomic disparities affect access to affordable, nutritious foods. Concurrently, the medical community bears responsibility for counseling patients on dietary risks and empowering lifestyle modifications.

Contributing to this research were medical students and faculty across institutions, emphasizing interdisciplinary collaboration in confronting complex health challenges. The application of a meta-analytic framework in the study enhances its validity by synthesizing extensive, nationally representative health data to yield actionable insights. The findings underscore the critical value of integrative research methodologies that bridge nutrition science, epidemiology, and clinical care.

As ultra-processed foods continue to dominate grocery shelves and consumer preferences, the mounting evidence linking these products to inflammation and disease calls for urgent attention. Bridging scientific insights with comprehensive healthcare strategies and regulatory frameworks is essential to stem the tide of chronic disease surge driven in part by dietary factors. This study marks a pivotal contribution to understanding the biochemical and epidemiological underpinnings of how modern diets impact health, reinforcing the timeless wisdom of returning to minimally processed, nutrient-rich foods for optimal wellbeing.

The pervasive infiltration of ultra-processed foods into daily caloric intake represents one of the most significant nutritional transitions in recent history. As scientific scrutiny intensifies, elucidating the molecular pathways by which these foods provoke systemic inflammation holds promise for targeted therapeutic interventions. Meanwhile, public health messaging and policy must keep pace to effectively counteract the risks posed by this hidden epidemic, empowering individuals and communities to reclaim dietary health in an increasingly industrialized food environment.

Subject of Research: People

Article Title: Ultra-Processed Foods and Increased High Sensitivity C-reactive Protein

News Publication Date: 3-Sep-2025

Web References:
https://www.fau.edu/medicine/
https://www.amjmed.com/article/S0002-9343(25)00549-2/abstract

References:
DOI: 10.1016/j.amjmed.2025.08.016

Image Credits: Alex Dolce, Florida Atlantic University

Keywords:
Human health, Diets, Cardiovascular disease, Symptomatology, Nutrition, Food additives, Food preservatives, Food chemistry, Food production, Food adulteration, Foods, Obesity, Age groups, Adults, Population, Physical exercise, Public health

Central to these discoveries are ellagitannins, a particular class of plant-derived polyphenols richly found in walnuts. Unlike many other dietary polyphenols, ellagitannins undergo exclusive metabolism by the gut microbiome, yielding a spectrum of metabolites collectively termed urolithins. Among these, urolithin A has garnered significant scientific interest due to its potent anti-inflammatory properties. Researchers led by Dr. Daniel W. Rosenberg have demonstrated that urolithin A can modulate inflammatory processes systemically, impacting not only peripheral blood markers but also the cellular environment within colonic tissues, which is critical in colorectal carcinogenesis.

Dr. Rosenberg, who holds the HealthNet Chair in Cancer Biology and serves as an Investigator in the Center for Molecular Oncology, has harnessed his extensive expertise developed over more than a decade to guide this pivotal trial. Prior preclinical studies had hinted at the anti-cancer benefits of walnuts in cancer-prone murine models, but this clinical investigation marks a vital translation to human populations at elevated risk for colon cancer, providing robust evidence for the nutraceutical potential of walnut ellagitannins via microbiome-mediated metabolism.

The study enrolled thirty-nine participants aged 40 to 65, all referred from UConn Health’s Division of Gastroenterology due to elevated colon cancer risk profiles. After rigorous initial screening and dietary standardization to eliminate confounding sources of ellagitannins, participants underwent a carefully monitored dietary intervention involving controlled walnut consumption over a three-week period. This protocol was followed by high-definition colonoscopies, enabling detailed visualization and tissue sampling for downstream molecular analysis.

One of the study’s most remarkable findings was the positive correlation between urolithin A levels in patients’ urine and serum levels of peptide YY, a gut-derived peptide implicated in the inhibition of colorectal cancer progression. This correlation suggests that enhanced urolithin production via gut microbial activity may have downstream effects on peptide YY expression, reinforcing the multifaceted role of diet-microbiome interactions in cancer prevention mechanisms. Moreover, significant reductions in systemic inflammatory markers were documented, particularly pronounced in obese individuals, a subgroup often exhibiting heightened baseline inflammatory states and altered microbial profiles.

Advancing beyond systemic markers, the UConn research team employed cutting-edge high-dimensional spatial imaging technology to interrogate the microenvironment of colon polyps excised post-intervention. This sophisticated imaging enabled unprecedented insight into cellular interactions and protein expression within polyp tissues, revealing that participants with higher urolithin A levels exhibited marked decreases in pro-inflammatory and pro-cancerous proteins. Notably, levels of vimentin, a protein linked to epithelial-mesenchymal transition and advanced tumor phenotypes in colorectal cancer, were substantially reduced.

This multidimensional approach elucidates a compelling biological narrative: walnut-derived ellagitannins, through gut microbiome metabolism, produce urolithin A, which exerts localized anti-inflammatory and anti-carcinogenic effects within the colon, while simultaneously modulating systemic inflammatory processes. These findings not only corroborate earlier animal model data but also provide strong mechanistic evidence supporting dietary walnuts as a non-invasive, accessible strategy to modulate colon cancer risk.

The implications of this research extend into preventive medicine and nutritional epidemiology, emphasizing the importance of personalized nutrition. The differential capacity of individuals’ gut microbiota to convert ellagitannins into bioactive urolithins underlines the potential for precision dietary recommendations tailored to microbiome characteristics, a frontier in optimizing cancer prevention strategies.

Importantly, the study also highlights public health relevance, given walnuts’ palatability, availability, and safety profile. The minimal risk associated with walnut consumption juxtaposed against the outlined benefits suggests a straightforward, practical intervention that could be easily incorporated into daily dietary routines to complement existing cancer risk reduction efforts.

The research was made possible through generous funding from the American Institute for Cancer Research, the California Walnut Commission, and the National Cancer Institute. This support underscores the collaborative effort bridging nutritional science, oncology, and microbiomics to uncover novel preventive measures for cancer and chronic inflammatory diseases.

Looking forward, Dr. Rosenberg and his multidisciplinary team advocate for broader clinical studies to validate these findings across diverse populations and to further unravel the molecular underpinnings of the walnut-microbiome-inflammation axis. The potential for urolithin A or derivative compounds to serve as biomarkers or therapeutic agents is a promising avenue poised to transform nutrition-based preventive oncology.

In conclusion, this landmark study encapsulates the remarkable potential of dietary walnuts to favorably transform the inflammatory milieu associated with colon carcinogenesis. Through a sophisticated interplay of gut microbiome metabolism and systemic immune modulation, walnuts emerge not only as a nutrient-rich food but also as a functional component with tangible anti-inflammatory and anti-cancer benefits. For individuals seeking accessible means to reduce their cancer risk and enhance colon health, incorporating a daily handful of walnuts could be a scientifically grounded, impactful choice.

Subject of Research: People
Article Title: Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
News Publication Date: 1-Apr-2025
Web References: https://aacrjournals.org/cancerpreventionresearch/article/18/4/235/754306/Systemic-Inflammation-and-the-Inflammatory-Context
Keywords: Colon cancer, Inflammation, Preventive medicine